Literature DB >> 16045296

Enhanced virtual screening by combined use of two docking methods: getting the most on a limited budget.

Vladimir Maiorov1, Robert P Sheridan.   

Abstract

Flexible ligand docking is a routine part of a modern structure-based lead discovery process. As of today, there are quite a number of commercial docking programs that can be used to screen large databases (hundreds of thousands to millions of compounds). However, limiting factors such as the number of commercial software licenses needed to perform docking simultaneously on multiple processors ("software cost") and the relatively long time required per molecule to get good results ("quality-to-speed") should be taken into account when planning a large docking run. How can we optimize the efficiency of selecting lead candidates by docking, in respect to the quality of the results, search speed, and software cost? We present a combination of two methods, our "fast-free-approximate" in-house docking program and the "slow-costly-accurate" ICM-Dock, as an example of one solution to the problem. Our proposed protocol is illustrated by a series of virtual screening experiments aimed at identifying active compounds in the MDL Drug Data Report database. In more than half of the 20 cases examined, at least several actives per protein target were identified in approximately 24 hours per target.

Mesh:

Substances:

Year:  2005        PMID: 16045296     DOI: 10.1021/ci050089y

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  4 in total

1.  Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V.

Authors:  Kenneth Segers; Olivier Sperandio; Markus Sack; Rainer Fischer; Maria A Miteva; Jan Rosing; Gerry A F Nicolaes; Bruno O Villoutreix
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

2.  VSDMIP: virtual screening data management on an integrated platform.

Authors:  Rubén Gil-Redondo; Jorge Estrada; Antonio Morreale; Fernando Herranz; Javier Sancho; Angel R Ortiz
Journal:  J Comput Aided Mol Des       Date:  2008-10-22       Impact factor: 3.686

3.  Investigating combinatorial approaches in virtual screening on human inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3): a case study for small molecule kinases.

Authors:  Robert B Crochet; Michael C Cavalier; Minsuh Seo; Jeong Do Kim; Young-Sun Yim; Seung-Jong Park; Yong-Hwan Lee
Journal:  Anal Biochem       Date:  2011-07-02       Impact factor: 3.365

4.  Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screening.

Authors:  Bruno O Villoutreix; Guillaume Laconde; David Lagorce; Pierre Martineau; Maria A Miteva; Piona Dariavach
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.